BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bravo PE. Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy? J Nucl Cardiol 2019;26:1125-34. [DOI: 10.1007/s12350-018-1298-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Galluzzo A, Fiorelli F, Rossi VA, Monzo L, Montrasio G, Camilli M, Halasz G, Uccello G, Mollace R, Beltrami M. Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time. Life (Basel) 2023;13. [PMID: 36676118 DOI: 10.3390/life13010171] [Reference Citation Analysis]
2 Zhan J, Zhong L, Wu J. Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.899099] [Reference Citation Analysis]
3 Monda E, Palmiero G, Lioncino M, Rubino M, Cirillo A, Fusco A, Caiazza M, Verrillo F, Diana G, Mauriello A, Iavarone M, Losi MA, De Rimini ML, Dellegrottaglie S, D'Andrea A, Bossone E, Pacileo G, Limongelli G. Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes. J Clin Med 2022;11:868. [PMID: 35160323 DOI: 10.3390/jcm11030868] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
4 Das A, Kelly C, Teh I, Nguyen C, Brown LAE, Chowdhary A, Jex N, Thirunavukarasu S, Sharrack N, Gorecka M, Swoboda PP, Greenwood JP, Kellman P, Moon JC, Davies RH, Lopes LR, Joy G, Plein S, Schneider JE, Dall'Armellina E. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes. Eur Heart J Cardiovasc Imaging 2021:jeab210. [PMID: 34694365 DOI: 10.1093/ehjci/jeab210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Aguiar Rosa S, Rocha Lopes L, Fiarresga A, Ferreira RC, Mota Carmo M. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact. Microcirculation 2021;28:e12656. [PMID: 32896949 DOI: 10.1111/micc.12656] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2019: Positron emission tomography, computed tomography and magnetic resonance. J Nucl Cardiol 2020;27:921-30. [PMID: 32410058 DOI: 10.1007/s12350-020-02151-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Sciagrà R. Microvascular Dysfunction in Hypertrophic Cardiomyopathy. Curr Cardiovasc Imaging Rep 2019;12. [DOI: 10.1007/s12410-019-9478-4] [Reference Citation Analysis]
8 Kay GN. Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy? J Nucl Cardiol 2019;26:1135-7. [PMID: 29761308 DOI: 10.1007/s12350-018-1299-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]